Semax
ACTH-derived synthetic peptide analog
Semax is discussed in neurobiology research involving melanocortin-related signaling and neurotrophic pathways.
Open Semax hub →Research comparison
Semax vs Selank
A research-focused comparison of compound identity, research mechanism, evidence maturity and documentation. This page does not provide dosing or medical guidance.
VS
Selank
Tuftsin-derived synthetic heptapeptide
Selank is discussed in neurobehavioral and immune-related research, including anxiety-model and neurotransmitter studies.
Open Selank hub →Key distinction
What is the main difference?
Semax and Selank arise from different parent peptide systems and have different experimental research histories.
Research overlap
Where do the research areas overlap?
They are often grouped together because both are discussed in neuropeptide research, not because they are the same class.
Evidence context
How should the evidence be compared?
Much of the literature is region-specific; source quality and study design should be reviewed carefully.
Use primary sources.Compare model type, study population, route of administration, endpoint and molecular form before drawing conclusions across compounds.
Independent literature
Research both compounds independently
FAQ
Semax vs Selank FAQ
Are Semax and Selank the same compound?
No. They have distinct molecular identities and should be researched and documented separately.
Which one has stronger evidence?
Evidence strength depends on the specific research question. Compare the number and quality of human studies, preclinical studies, study design and whether the exact molecular form matches the compound being discussed.
Can findings from one be applied to the other?
Not automatically. Findings should remain tied to the compound, model, dose, route and endpoint used in the original study.
Where can I verify NPC product documentation?
Use Northern Peptide Collective's COA Verification page and match analytical documentation to the exact product lot where available.